Lactose intolerance (LI)—affecting about two-thirds of the global population—can lead to poor diets by limiting the intake of nutrient-rich foods such as milk and milk products. Traditional management strategies—reducing lactose intake or using lactase enzyme supplements to digest lactose (milk sugar)—can help, but symptom relief is often inconsistent.
Increasingly, attention has turned to whether the gut microbiome can be leveraged to improve lactose digestion. Probiotics and prebiotics, in particular, are being studied for their potential to reduce symptoms and enhance tolerance. This IPA article will briefly summarize the relevant research.
Lactose intolerance, an overview
Lactose intolerance is a clinical condition characterized by symptoms such as abdominal pain, bloating, flatulence, and diarrhea following lactose consumption. It is important to distinguish LI from lactose maldigestion (reduced enzymatic breakdown) and lactose malabsorption (incomplete absorption), both of which may occur without symptoms.
Lactase (β-galactosidase), the enzyme located on the brush border of the small intestine, hydrolyzes lactose into glucose and galactose. When lactase activity is insufficient, undigested lactose passes into the colon, where it is fermented by gut microbes, producing gases and metabolites that contribute to gastrointestinal symptoms.
As noted, not everyone with lactose malabsorption develops symptoms. Symptom expression depends on multiple factors, including lactase activity, the amount of lactose consumed, visceral sensitivity, and the composition of the gut microbiome.
Causes of lactase deficiency
Lactase deficiency may be:
- Primary (lactase non-persistence): a genetically programmed decline in lactase activity after childhood—the most common form worldwide—which affects more people in African, Asian, and South American countries and fewer in northern Europe.
- Secondary: resulting from intestinal injury such as infections, celiac disease, or Crohn’s disease
- Congenital: a rare genetic condition characterized by little to no lactase activity from birth
Diagnosis
Diagnosis is typically based on evidence of a genetic mutation, loss of lactase activity in the enteric mucosa, or the presence of symptoms after lactose ingestion, supported by objective testing. The hydrogen breath test (HBT) is a widely used low-cost method to detect malabsorption. Current guidance suggests that diagnosis is most reliable when symptoms are accompanied by abnormal breath test results.
Management
Reducing lactose intake remains a central strategy, but complete elimination is no longer routinely recommended. A 2026 review noted that many individuals with LI can tolerate approximately 12–15 grams of lactose (about one cup of milk), particularly when consumed with meals, which slows gastric emptying and improves tolerance.
Additional strategies include:
Lactose-free or lactose-reduced dairy products: exogenous lactase to hydrolyze the lactose into glucose and galactose is added.
- Plant-based dairy alternatives, such as soy, almond, or oat milk, are another option, and these are frequently fortified with essential nutrients.
- Lactase enzyme supplements, though their effectiveness can vary.
- Yogurt and cultured fermented milk are often better tolerated due to lower lactose content and microbial enzyme activity, such as β-galactosidase. Fresh yogurt may provide greater symptom relief than pasteurized forms. Notably, yogurt is the only probiotic-containing food to receive a positive opinion from the European Food Safety Authority (EFSA) for improving lactose digestion. (EFSA Journal. 2010;8(10):1763)
- Attention should be given to the small amounts of lactose present in processed foods and medications, which can contribute to symptoms in sensitive individuals.
Nutritional consequences
Dairy products are key sources of calcium, potassium, protein, and vitamins B and D. Long-term avoidance without appropriate dietary substitutions may increase the risk of nutrient deficiencies and bone-related conditions.
Lactose and the gut microbiome
Specific probiotic strains produce β-galactosidase and may support lactose digestion. After being consumed, galactosidase-producing probiotic strains survive the passage through the stomach and hydrolyze undigested lactose in the small intestine.
Recent research highlights a dynamic relationship between lactose intake and the gut microbiome. Regular lactose consumption may promote colonic adaptation, whereby lactose-fermenting bacteria—particularly Bifidobacterium and Lactobacillus species—increase in abundance. This can enhance microbial β-galactosidase activity and improve tolerance over time.
Importantly, this adaptation appears to be reversible. When lactose is eliminated from the diet, these microbial changes may diminish, and symptoms can recur upon reintroduction. Regular low-to-moderate lactose exposure may enhance adaptation.
Probiotics and lactose intolerance
Specific strains of Lactobacillus, Bifidobacterium, and Streptococcus thermophilus are known to have high β-galactosidase activity, suggesting a strong potential to assist in lactose digestion and ameliorate symptoms of LI. Several recent reviews have looked at the research.
- A 2018 systematic review of 15 studies with eight probiotic strains studied found "an overall positive relationship between probiotics and LI."
- A 2020 review, including a final nine studies, reported that probiotic supplementation improved hydrogen breath test results and symptoms of LI. Most of the probiotics administered (including L. acidophilus, L. reuteri, L. rhamnosus, L. bulgaricus, S. thermophilus, and B. longum) effectively mitigated clinical signs. The dose and duration of probiotic treatment, as well as the age of participants, were observed to be critical to outcomes.
- A 2022 review that included five studies concluded that L.reuteri and L. acidophilus strains showed the best results in managing LI symptoms.
- A 2023 meta-analysis of 12 studies found that probiotic intervention reduced clinical symptoms of LI. Single-strain probiotics were more effective at reducing both abdominal pain and total symptom scores, while multi-strain probiotics were better at reducing flatulence.
Reviewers caution that probiotic effects in lactose intolerance are strain-specific and dose-dependent, and not all products are effective.
How might probiotics work?
Proposed mechanisms include:
- Delivery of microbial β-galactosidase to support lactose digestion
- Modulation of gut microbiota, including suppression of gas-producing species
- Production of metabolites that influence gut function
- Support of intestinal barrier integrity and immune signaling
Prebiotics, synbiotics and lactose intolerance
A prebiotic is defined as “a substrate that is selectively utilized by host microorganisms conferring a health benefit.” Prebiotics such as non-digestible oligosaccharides, including fructans and galactans, stimulate the growth and modulate the metabolic activity of gut microbiota.
Evidence for prebiotics alone remains limited, though certain compounds—such as galacto-oligosaccharides (GOS)—have shown potential to improve symptoms by promoting the growth of lactose-fermenting bacteria.
Synbiotics*, which combine probiotics and prebiotics, are also being explored as a strategy to enhance microbial survival and function. Early findings are promising, though further research is needed to confirm their clinical effectiveness.
* "a mixture comprising live microorganisms and substrate(s) selectively utilized by host microorganisms that confers a health benefit on the host."
Takeaway
Lactose intolerance is highly prevalent and can affect both quality of life and nutrient intake, particularly when dairy is unnecessarily restricted. While traditional strategies—such as reducing lactose intake or using lactase supplements—remain helpful, they are not always sufficient or consistent.
A more nuanced approach is emerging. Many individuals can tolerate modest amounts of lactose, especially when consumed with meals, and regular intake may promote microbiome adaptation, increasing lactose-fermenting bacteria and improving tolerance over time.
Yogurt remains the only probiotic-containing food to receive a positive opinion from the European Food Safety Authority for improving lactose digestion. Beyond this, growing evidence suggests that specific probiotic strains, delivered at appropriate doses and durations, may reduce symptoms and enhance tolerance—though effects are strain-specific and not universal.
Prebiotics and synbiotics show additional promise, but evidence remains limited. Overall, microbiome-targeted strategies may complement—not replace—current management, with future research needed to refine personalized approaches.
Key references
Ahn, Sung-Il et al. “Effects of probiotics administration on lactose intolerance in adulthood: A meta-analysis.” Journal of dairy science vol. 106,7 (2023): 4489-4501. doi:10.3168/jds.2022-22762
Almukainzi, May et al. “Using medications containing lactose as an excipient for lactose intolerance patients: Insights of clinical practices and regulators roles.” Journal of the American Pharmacists Association : JAPhA vol. 65,6 (2025): 102476. doi:10.1016/j.japh.2025.102476
Azcarate-Peril, M Andrea et al. “Impact of short-chain galactooligosaccharides on the gut microbiome of lactose-intolerant individuals.” Proceedings of the National Academy of Sciences of the United States of America vol. 114,3 (2017): E367-E375. doi:10.1073/pnas.1606722113
Di Costanzo, Margherita, and Roberto Berni Canani. "Lactose Intolerance: Common Misunderstandings." Annals of nutrition & metabolism vol. 73 Suppl 4 (2018): 30-37. doi:10.1159/000493669
Fassio, Filippo et al. "Lactose Maldigestion, Malabsorption, and Intolerance: A Comprehensive Review with a Focus on Current Management and Future Perspectives." Nutrients vol. 10,11 1599. 1 Nov. 2018, doi:10.3390/nu10111599
Hodges, Joanna K et al. “Lactose Intolerance and Bone Health: The Challenge of Ensuring Adequate Calcium Intake.” Nutrients vol. 11,4 718. 28 Mar. 2019, doi:10.3390/nu11040718
Ibba, Ivan et al. "Effects of exogenous lactase administration on hydrogen breath excretion and intestinal symptoms in patients presenting lactose malabsorption and intolerance." BioMed research international vol. 2014 (2014): 680196. doi:10.1155/2014/680196
JanssenDuijghuijsen, Lonneke et al. “Changes in gut microbiota and lactose intolerance symptoms before and after daily lactose supplementation in individuals with the lactase nonpersistent genotype.” The American journal of clinical nutrition vol. 119,3 (2024): 702-710. doi:10.1016/j.ajcnut.2023.12.016
Labayen, I et al. “Relationship between lactose digestion, gastrointestinal transit time and symptoms in lactose malabsorbers after dairy consumption.” Alimentary pharmacology & therapeutics vol. 15,4 (2001): 543-9. doi:10.1046/j.1365-2036.2001.00952.x
Leis, Rosaura et al. "Effects of Prebiotic and Probiotic Supplementation on Lactase Deficiency and Lactose Intolerance: A Systematic Review of Controlled Trials." Nutrients vol. 12,5 1487. 20 May. 2020, doi:10.3390/nu12051487
Matthews, S B et al. “Systemic lactose intolerance: a new perspective on an old problem.” Postgraduate medical journal vol. 81,953 (2005): 167-73. doi:10.1136/pgmj.2004.025551
Misselwitz, Benjamin et al. "Update on lactose malabsorption and intolerance: pathogenesis, diagnosis and clinical management." Gut vol. 68,11 (2019): 2080-2091. doi:10.1136/gutjnl-2019-318404
Oak, Sophia J, and Rajesh Jha. "The effects of probiotics in lactose intolerance: A systematic review." Critical reviews in food science and nutrition vol. 59,11 (2019): 1675-1683. doi:10.1080/10408398.2018.1425977
Oliveira, Luiza Scalcon de et al. "The use of probiotics and prebiotics can enable the ingestion of dairy products by lactose intolerant individuals." Clinical nutrition (Edinburgh, Scotland) vol. 41,12 (2022): 2644-2650. doi:10.1016/j.clnu.2022.10.003
Perets, Tsachi Tsadok et al. “Lactose intolerance and probiotics: from pathophysiological mechanisms to clinical applications.” Antonie van Leeuwenhoek vol. 119,4 67. 17 Mar. 2026, doi:10.1007/s10482-026-02278-x
Rezaie, Ali et al. “Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus.” The American journal of gastroenterology vol. 112,5 (2017): 775-784. doi:10.1038/ajg.2017.46
Savaiano, Dennis A et al. "Improving lactose digestion and symptoms of lactose intolerance with a novel galacto-oligosaccharide (RP-G28): a randomized, double-blind clinical trial." Nutrition journal vol. 12 160. 13 Dec. 2013, doi:10.1186/1475-2891-12-160
Savaiano, Dennis A, and Robert W Hutkins. “Yogurt, cultured fermented milk, and health: a systematic review.” Nutrition reviews vol. 79,5 (2021): 599-614. doi:10.1093/nutrit/nuaa013







